Notably, a comparison of DLBCL patients with the highest versus lowest expression levels for ERBB1 mRNA in their MLC revealed a significantly worse OS outcome for the EGFR/ERBB1high group. The gene discussed is EGFR; the disease is diffuse large B-cell lymphoma.